Results 241 to 250 of about 51,821 (267)

Clinical pharmacology of inhibitors of platelet aggregation

Pharmacological Research Communications, 1979
openaire   +2 more sources

Platelet aggregation inhibitors for laminitis

Journal of Equine Veterinary Science, 1998
openaire   +1 more source

Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans

Circulation, 2011
Meinrad Gawaz
exaly  

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh   +2 more
exaly  

2-Methylthioadenosine-5′-phosphate: a Specific Inhibitor of Platelet Aggregation

Nature, 1969
Lisa Kouladjian
exaly  

Forskolin (a powerful inhibitor of human platelet aggregation)

Biochemical Pharmacology, 1982
S, Adnot, M, Desmier, N, Ferry, J, Hanoune, T, Sevenet   +4 more
openaire   +2 more sources

PLATELET-MEMBRANE FATTY ACIDS, PLATELET AGGREGATION, AND THROMBOXANE FORMATION DURING A MACKEREL DIET

Lancet, The, 1980
exaly  

DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRIN

Lancet, The, 1979
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

Lancet, The, 2002
Harvey D White, Paul W Armstrong, Robert M Califf   +2 more
exaly